Nafarelin is currently used as a treatment for mild-to-severe ...

[bobthebuilder]

Nafarelin is currently used as a treatment for mild-to-severe endometriosis. The nurse should tell a woman taking this medication that the drug:
 
  a. Stimulates the secretion of gonadotropin-releasing hormone (GnRH), thereby stimulating ovarian activity.
  b. Should be sprayed into one nostril every other day.
  c. Should be injected into subcutaneous tissue BID.
  d. Can cause her to experience some hot flashes and vaginal dryness.

Question 2

A 36-year-old woman has been given a diagnosis of uterine fibroids. When planning care for this patient, the nurse should know that:
 
  a. Fibroids are malignant tumors of the uterus that require radiation or chemotherapy.
  b. Fibroids increase in size during the perimenopausal period.
  c. Menorrhagia is a common finding.
  d. The woman is unlikely to become pregnant as long as the fibroids are in her uterus.

[amy.lauersdorf90]

Answer to Question 1

ANS: D
Nafarelin is a GnRH agonist, and its side effects are similar to effects of menopause. The hypoestrogenism effect results in hot flashes and vaginal dryness. Nafarelin is a GnRH agonist that suppresses the secretion of GnRH and is administered twice daily by nasal spray.

Answer to Question 2

ANS: C
The major symptoms associated with fibroids are menorrhagia and the physical effects produced by large myomas. Fibroids are benign tumors of the smooth muscle of the uterus, and their etiology is unknown. Fibroids are estrogen sensitive and shrink as levels of estrogen decline. Fibroids occur in 25 of women of reproductive age and are seen in 2 of pregnant women.